Electrochemical behavior of Hy-HCl
The electrochemical behavior of Hy-HCl was first studied at bare GCE and at different pH values. Cyclic voltammetry studies in aqueous solutions showed that the electrode reaction of Hy-HCl was an irreversible oxidation process and good sensitivities could be achieved within neutral pH values (
Figure 1). Increasing pH of the solution shifted the peak potentials toward less positive values. The plot of peak potential versus solution pH between 2.0 and 8.0 showed a straight line expressed by the Equation y = -0.078x + 0.700 (R
2 > 0.99). Considering the electrochemical oxidation of hydrazine compounds a 5H
+/4e mechanism is expected for Hy-HCl (
32). The proposed electrooxidation mechanism for this compound is depicted in
Scheme 2.
Figure 2A shows the cyclic voltammograms of Hy-HCl at bare GCE at different concentrations. As seen, the shape of CV is concentration dependent. At lower concentrations the CV shows a “post wave” which might be either due to the strong adsorption of the reactant at the electrode surface (
33) or formation of some electroactive products. At higher concentrations, however, these small waves are not observable.
Figure 2B displays successive cyclic voltammograms recorded at a GCE in 0.1 M PBS solution already dipped in a 0.2 µM solution of Hy-HCl for 60 sec. The first cycle shows the post waves following an irreversible wave at 0.1 V. The peak at 0.1 V reflects the weakly adsorbed analyte on the electrode surface since it completely disappeared after the first cycle. The pair at 0.142 and 0.162 V, however, was still observable and stable after five scans and varied linearly with scan rate (v) (R
2 > 0.99), which implies a surface confined process. Our preliminary studies revealed that Hy-HCl could be efficiently accumulated on MWCNT modified electrodes. Therefore, experiments with GCE and electrodes modified with MWCNT were carried out in order to probe the electrochemical behavior of Hy-HCl on these electrodes. In all experiments, the cyclic voltammograms were recorded with electrodes submerged in a PB solution containing 0.4 µM Hy-HCl adjusted to pH 7.0 and an accumulation time of 60 sec. As shown (
Figure 3), a weak anodic peak corresponding to the oxidation of Hy-HCl is observed on the GC electrode (curve a), while on the MWCNT/GCE the peak current increased substantially (curve b). Clearly, modification of glassy carbon electrode with MWCNTs leads to a strong accumulation of Hy-HCl, which provides a preconcentration step for highly sensitive adsorptive stripping measurements. Also, the oxidation of Hy-HCl at MWCNT occurred at a lower potential (~32 mV) than that observed at bare GCE (~52 mV). The excellent properties of MWCNT, such as its high electrical conductivity and high surface area may also contribute to the observed electrochemical response.
The scanning electron micrographs (insets of
Figure 3) clearly shows that the MWCNTs are distributed uniformly on the surface glassy carbon (b). The diameter of the nanotube deposits was found to be about 30 to 50 nm. The spaghetti-like MWCNTs formed a porous structure leading to an increased surface area and hence an enhanced electrochemical response.
Effects of accumulation potential and time
The oxidation peak current of Hy-HCl (0.22 µM) was measured by cyclic voltammetry after 60 sec accumulation time at different potential values from -0.2 to 0.5 V in 0.1 PBS (pH 7.0). It was observed (data not shown) that the oxidation peak current of Hy-HCl was remained unchanged up to 0.1 V and thereafter decreased rapidly with accumulation potential. Our results, however, showed that the drug can be effectively accumulated on MWCNT surface without any applied potential. The preconcentration, therefore, was performed under open-circuit potential.
Figure 4 shows the influence of accumulation time on the oxidation peak current of 0.22 µM Hy-HCl. The current was increased greatly at first, and then decreased after 140 sec due to the adsorption saturation. An accumulation time of 120 sec was chosen for subsequent experiments.
Adsorptive stripping voltammetric determination of Hy-HCl
To estimate the lower detection limit and the linear calibration range of Hy-HCl, DPV method was used. The DPVs were recorded by changing the concentration of Hy-HCl. As can be seen from
Figure 5, an anodic peak at 70 mV was appeared. The analytical plot was linear in the concentration range of 10-220 nM (R
2 = 0.999) Hy-HCl. The limit of detection (LOD) were calculated from the Equation LOD = 3 s/m; where s represents the standard deviation of the signal of the blank (n = 6) and m represents the slope of the calibration curve.
The LOD of Hy-HCl was found to be 2.7 nM. The repeatability was determined by successive measurements (n = 5) of a 50 nM Hy-HCl solution and relative standard deviations of 1.81% was obtained. These results clearly indicate that the proposed electrode can be utilized for the sensitive and precise determination of this compound.
Interference studies
The effect of some interfering substances was investigated by adding the compounds to a solution containing 50 nM Hy-HCl in 0.1 M PBS (pH 7.0). The tolerance limit was taken as the maximum concentration of the foreign substances, which caused an approximately ±5% relative error in the determination of the analyte. Common ions such as Na+, K+, Cl-, CO32-, PO43-, and SO42- as well as starch did not show any interference with Hy-HCl detection.
The results showed that 800-fold saccharin, glucose, sucrose, urea; 600-fold glycine, phenylalanine, lysine, glutathione, citric acid, 350-fold ascorbic acid, uric acid, Cu
2+, and 2-fold dopamine are tolerable in voltammetric determination of Hy-HCl.
Figure 6 represents DPVs of Hy-HCl in the presence of increasing concentrations of some interfering species.
Analytical application
The proposed electrode was used to analyze Hy-HCl in pharmaceutical formulations (
Table 1). The results were satisfactory with the recoveries ranging from 98.5 to 102.0%. From these results, it can be concluded that the MWCNT/GCE shows good performance for the routine analysis of this compound in pharmaceutical formulations.